Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. HI BioHistory (TM)
Career
Job Search Post a Job Destination HI
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
Patient
 Clinical Trials
 Drug Development
 Resources
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
 
Community Service Ad: National Center for Missing & Exploited Children
Want to target global biotech trade media?  Use B3C newswire  services.
 
Advertising
 
UW Master’s in Biomedical Regulatory Affairs: addressing devices, drugs & biologics. Apply now.

Application Fileable?

The New Drug Development Process.

After a New Drug Application (NDA) is received by the agency, it undergoes a technical screening generally referred to as a completeness review. This evaluation ensures that sufficient data and information have been submitted in each area to justify "filing" the application--that is, justifying initiating CDER's formal review of the NDA.





Source: U.S. Food and Drug Administration Center for Drug Evaluation and Research Handbook.


Back to The New Drug Development Process

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2012 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advertising

HawaiiLifeScience.com is owned and published by Info.Resource, Inc.